Clinical trial
Pharmacovigilance Evaluation Of Refacto Af (Registered) In Germany And Austria
NCT00895037 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacovigilance Evaluation Of Refacto Af (Registered) In Germany And Austria
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 17, 2009
- Completion date
- October 19, 2016
- Enrollment
- 101 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.